Lars G. Ekman is a businessperson who founded Cebix, Inc. and who has been the head of 7 different companies. Currently, Dr. Ekman holds the position of Chairman of Prothena Corp. Plc, Chairman of Prothena Biosciences, Inc. (a subsidiary of Prothena Corp. Plc), Chairman for AFYX Therapeutics AS and Executive Partner & Private Equity at Sofinnova Investments, Inc. Lars G. Ekman is also on the board of Amarin Corp. Plc (former Non-Executive Chairman) and Ultragenyx Pharmaceutical, Inc.

In his past career Dr. Ekman held the position of Executive Chairman of Sophiris Bio, Inc., Chairman for Poseida Therapeutics, Inc., Chief Executive Officer of Cebix, Inc., Executive Vice President-Research & Development at Schwartz Pharma AG, Director at Elan Corp. Plc, EVP, President-Research & Development at Elan Pharmaceuticals, LLC and Principal at Pharmacia Corp.

He received a doctorate from the University of Gothenburg.